BUY CHAPTERS

Global Onco-hematology Molecular Testing Market Research Report 2023

Q: How big is the oncohematology molecular testing market?

According to QYResearchs new survey global Oncohematology Molecular Testing market is projected to reach US 1163.7 million in 2029 increasing from US 511 million in 2022 with the CAGR of 12.5 during the period of 2023 to 2029.

Q: Who are the key players in the oncohematology molecular testing market?

Some of the key players are Companies, Companies, Integrated DNA Technologies, Inc., Qiagen NV, Qiagen, Thermo Fisher Scientific Inc, Others.

Code: QYRE-Auto-13I14977

Report

July 2023

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

Integrated DNA Technologies, Inc.

Qiagen NV

Qiagen

Thermo Fisher Scientific Inc

Bio-Rad Laboratories Inc

Onco-hematology Molecular Testing Market Size

According to QYResearch’s new survey, global Onco-hematology Molecular Testing market is projected to reach US$ 1163.7 million in 2029, increasing from US$ 511 million in 2022, with the CAGR of 12.5% during the period of 2023 to 2029.

Onco-hematology Molecular Testing Market

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Onco-hematology Molecular Testing market research.

Key companies engaged in the Onco-hematology Molecular Testing industry include Asusragen, Inc., Bio-Rad Laboratories,Inc., ICON Plc, Integrated DNA Technologies, Inc., Illumina, Inc., Invivoscribe, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc. and Cepheid, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Onco-hematology Molecular Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Onco-hematology Molecular Testing market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Onco-hematology Molecular Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Onco-hematology Molecular Testing Market Report

Report Metric	Details
Report Name	Onco-hematology Molecular Testing Market
Accounted market size in 2022	US$ 511 million
Forecasted market size in 2029	US$ 1163.7 million
CAGR	12.5%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	qPCR dPCR Next-Generation Sequencing Others
Segment by Application	National Reference Lab / Specialty Lab University Hospital Community Hospital
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Asusragen, Inc., Bio-Rad Laboratories,Inc., ICON Plc, Integrated DNA Technologies, Inc., Illumina, Inc., Invivoscribe, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., Cepheid
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Onco-hematology Molecular Testing Market market growing?

Ans: The Onco-hematology Molecular Testing Market market witnessing a CAGR of 12.5% during the forecast period 2023-2029.

What is the Onco-hematology Molecular Testing Market market size in 2029?

Ans: According to QYResearch’s new survey, global Onco-hematology Molecular Testing market is projected to reach US$ 1163.7 million in 2029, increasing from US$ 511 million in 2022, with the CAGR of 12.5% during the period of 2023 to 2029.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Onco-hematology Molecular Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 qPCR

1.2.3 dPCR

1.2.4 Next-Generation Sequencing

1.2.5 Others

1.3 Market by Application

1.3.1 Global Onco-hematology Molecular Testing Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 National Reference Lab / Specialty Lab

1.3.3 University Hospital

1.3.4 Community Hospital

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Onco-hematology Molecular Testing Market Perspective (2018-2029)

2.2 Onco-hematology Molecular Testing Growth Trends by Region

2.2.1 Global Onco-hematology Molecular Testing Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Onco-hematology Molecular Testing Historic Market Size by Region (2018-2023)

2.2.3 Onco-hematology Molecular Testing Forecasted Market Size by Region (2024-2029)

2.3 Onco-hematology Molecular Testing Market Dynamics

2.3.1 Onco-hematology Molecular Testing Industry Trends

2.3.2 Onco-hematology Molecular Testing Market Drivers

2.3.3 Onco-hematology Molecular Testing Market Challenges

2.3.4 Onco-hematology Molecular Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Onco-hematology Molecular Testing Players by Revenue

3.1.1 Global Top Onco-hematology Molecular Testing Players by Revenue (2018-2023)

3.1.2 Global Onco-hematology Molecular Testing Revenue Market Share by Players (2018-2023)

3.2 Global Onco-hematology Molecular Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Onco-hematology Molecular Testing Revenue

3.4 Global Onco-hematology Molecular Testing Market Concentration Ratio

3.4.1 Global Onco-hematology Molecular Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Onco-hematology Molecular Testing Revenue in 2022

3.5 Onco-hematology Molecular Testing Key Players Head office and Area Served

3.6 Key Players Onco-hematology Molecular Testing Product Solution and Service

3.7 Date of Enter into Onco-hematology Molecular Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Onco-hematology Molecular Testing Breakdown Data by Type

4.1 Global Onco-hematology Molecular Testing Historic Market Size by Type (2018-2023)

4.2 Global Onco-hematology Molecular Testing Forecasted Market Size by Type (2024-2029)

5 Onco-hematology Molecular Testing Breakdown Data by Application

5.1 Global Onco-hematology Molecular Testing Historic Market Size by Application (2018-2023)

5.2 Global Onco-hematology Molecular Testing Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Onco-hematology Molecular Testing Market Size (2018-2029)

6.2 North America Onco-hematology Molecular Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Onco-hematology Molecular Testing Market Size by Country (2018-2023)

6.4 North America Onco-hematology Molecular Testing Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Onco-hematology Molecular Testing Market Size (2018-2029)

7.2 Europe Onco-hematology Molecular Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Onco-hematology Molecular Testing Market Size by Country (2018-2023)

7.4 Europe Onco-hematology Molecular Testing Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Onco-hematology Molecular Testing Market Size (2018-2029)

8.2 Asia-Pacific Onco-hematology Molecular Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Onco-hematology Molecular Testing Market Size by Region (2018-2023)

8.4 Asia-Pacific Onco-hematology Molecular Testing Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Onco-hematology Molecular Testing Market Size (2018-2029)

9.2 Latin America Onco-hematology Molecular Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Onco-hematology Molecular Testing Market Size by Country (2018-2023)

9.4 Latin America Onco-hematology Molecular Testing Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Onco-hematology Molecular Testing Market Size (2018-2029)

10.2 Middle East & Africa Onco-hematology Molecular Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Onco-hematology Molecular Testing Market Size by Country (2018-2023)

10.4 Middle East & Africa Onco-hematology Molecular Testing Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Asusragen, Inc.

11.1.1 Asusragen, Inc. Company Detail

11.1.2 Asusragen, Inc. Business Overview

11.1.3 Asusragen, Inc. Onco-hematology Molecular Testing Introduction

11.1.4 Asusragen, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)

11.1.5 Asusragen, Inc. Recent Development

11.2 Bio-Rad Laboratories,Inc.

11.2.1 Bio-Rad Laboratories,Inc. Company Detail

11.2.2 Bio-Rad Laboratories,Inc. Business Overview

11.2.3 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Introduction

11.2.4 Bio-Rad Laboratories,Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)

11.2.5 Bio-Rad Laboratories,Inc. Recent Development

11.3 ICON Plc

11.3.1 ICON Plc Company Detail

11.3.2 ICON Plc Business Overview

11.3.3 ICON Plc Onco-hematology Molecular Testing Introduction

11.3.4 ICON Plc Revenue in Onco-hematology Molecular Testing Business (2018-2023)

11.3.5 ICON Plc Recent Development

11.4 Integrated DNA Technologies, Inc.

11.4.1 Integrated DNA Technologies, Inc. Company Detail

11.4.2 Integrated DNA Technologies, Inc. Business Overview

11.4.3 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Introduction

11.4.4 Integrated DNA Technologies, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)

11.4.5 Integrated DNA Technologies, Inc. Recent Development

11.5 Illumina, Inc.

11.5.1 Illumina, Inc. Company Detail

11.5.2 Illumina, Inc. Business Overview

11.5.3 Illumina, Inc. Onco-hematology Molecular Testing Introduction

11.5.4 Illumina, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)

11.5.5 Illumina, Inc. Recent Development

11.6 Invivoscribe, Inc.

11.6.1 Invivoscribe, Inc. Company Detail

11.6.2 Invivoscribe, Inc. Business Overview

11.6.3 Invivoscribe, Inc. Onco-hematology Molecular Testing Introduction

11.6.4 Invivoscribe, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)

11.6.5 Invivoscribe, Inc. Recent Development

11.7 QIAGEN N.V.

11.7.1 QIAGEN N.V. Company Detail

11.7.2 QIAGEN N.V. Business Overview

11.7.3 QIAGEN N.V. Onco-hematology Molecular Testing Introduction

11.7.4 QIAGEN N.V. Revenue in Onco-hematology Molecular Testing Business (2018-2023)

11.7.5 QIAGEN N.V. Recent Development

11.8 Thermo Fisher Scientific, Inc.

11.8.1 Thermo Fisher Scientific, Inc. Company Detail

11.8.2 Thermo Fisher Scientific, Inc. Business Overview

11.8.3 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Introduction

11.8.4 Thermo Fisher Scientific, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)

11.8.5 Thermo Fisher Scientific, Inc. Recent Development

11.9 Cepheid

11.9.1 Cepheid Company Detail

11.9.2 Cepheid Business Overview

11.9.3 Cepheid Onco-hematology Molecular Testing Introduction

11.9.4 Cepheid Revenue in Onco-hematology Molecular Testing Business (2018-2023)

11.9.5 Cepheid Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Companies

Integrated DNA Technologies, Inc.

Qiagen NV

Qiagen

Thermo Fisher Scientific Inc

Bio-Rad Laboratories Inc

List of Tables

Table 1. Global Onco-hematology Molecular Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of qPCR

Table 3. Key Players of dPCR

Table 4. Key Players of Next-Generation Sequencing

Table 5. Key Players of Others

Table 6. Global Onco-hematology Molecular Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 7. Global Onco-hematology Molecular Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 8. Global Onco-hematology Molecular Testing Market Size by Region (2018-2023) & (US$ Million)

Table 9. Global Onco-hematology Molecular Testing Market Share by Region (2018-2023)

Table 10. Global Onco-hematology Molecular Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 11. Global Onco-hematology Molecular Testing Market Share by Region (2024-2029)

Table 12. Onco-hematology Molecular Testing Market Trends

Table 13. Onco-hematology Molecular Testing Market Drivers

Table 14. Onco-hematology Molecular Testing Market Challenges

Table 15. Onco-hematology Molecular Testing Market Restraints

Table 16. Global Onco-hematology Molecular Testing Revenue by Players (2018-2023) & (US$ Million)

Table 17. Global Onco-hematology Molecular Testing Market Share by Players (2018-2023)

Table 18. Global Top Onco-hematology Molecular Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onco-hematology Molecular Testing as of 2022)

Table 19. Ranking of Global Top Onco-hematology Molecular Testing Companies by Revenue (US$ Million) in 2022

Table 20. Global 5 Largest Players Market Share by Onco-hematology Molecular Testing Revenue (CR5 and HHI) & (2018-2023)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Onco-hematology Molecular Testing Product Solution and Service

Table 23. Date of Enter into Onco-hematology Molecular Testing Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Onco-hematology Molecular Testing Market Size by Type (2018-2023) & (US$ Million)

Table 26. Global Onco-hematology Molecular Testing Revenue Market Share by Type (2018-2023)

Table 27. Global Onco-hematology Molecular Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 28. Global Onco-hematology Molecular Testing Revenue Market Share by Type (2024-2029)

Table 29. Global Onco-hematology Molecular Testing Market Size by Application (2018-2023) & (US$ Million)

Table 30. Global Onco-hematology Molecular Testing Revenue Market Share by Application (2018-2023)

Table 31. Global Onco-hematology Molecular Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 32. Global Onco-hematology Molecular Testing Revenue Market Share by Application (2024-2029)

Table 33. North America Onco-hematology Molecular Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 34. North America Onco-hematology Molecular Testing Market Size by Country (2018-2023) & (US$ Million)

Table 35. North America Onco-hematology Molecular Testing Market Size by Country (2024-2029) & (US$ Million)

Table 36. Europe Onco-hematology Molecular Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. Europe Onco-hematology Molecular Testing Market Size by Country (2018-2023) & (US$ Million)

Table 38. Europe Onco-hematology Molecular Testing Market Size by Country (2024-2029) & (US$ Million)

Table 39. Asia-Pacific Onco-hematology Molecular Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 40. Asia-Pacific Onco-hematology Molecular Testing Market Size by Region (2018-2023) & (US$ Million)

Table 41. Asia-Pacific Onco-hematology Molecular Testing Market Size by Region (2024-2029) & (US$ Million)

Table 42. Latin America Onco-hematology Molecular Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Latin America Onco-hematology Molecular Testing Market Size by Country (2018-2023) & (US$ Million)

Table 44. Latin America Onco-hematology Molecular Testing Market Size by Country (2024-2029) & (US$ Million)

Table 45. Middle East & Africa Onco-hematology Molecular Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 46. Middle East & Africa Onco-hematology Molecular Testing Market Size by Country (2018-2023) & (US$ Million)

Table 47. Middle East & Africa Onco-hematology Molecular Testing Market Size by Country (2024-2029) & (US$ Million)

Table 48. Asusragen, Inc. Company Detail

Table 49. Asusragen, Inc. Business Overview

Table 50. Asusragen, Inc. Onco-hematology Molecular Testing Product

Table 51. Asusragen, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023) & (US$ Million)

Table 52. Asusragen, Inc. Recent Development

Table 53. Bio-Rad Laboratories,Inc. Company Detail

Table 54. Bio-Rad Laboratories,Inc. Business Overview

Table 55. Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Product

Table 56. Bio-Rad Laboratories,Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023) & (US$ Million)

Table 57. Bio-Rad Laboratories,Inc. Recent Development

Table 58. ICON Plc Company Detail

Table 59. ICON Plc Business Overview

Table 60. ICON Plc Onco-hematology Molecular Testing Product

Table 61. ICON Plc Revenue in Onco-hematology Molecular Testing Business (2018-2023) & (US$ Million)

Table 62. ICON Plc Recent Development

Table 63. Integrated DNA Technologies, Inc. Company Detail

Table 64. Integrated DNA Technologies, Inc. Business Overview

Table 65. Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Product

Table 66. Integrated DNA Technologies, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023) & (US$ Million)

Table 67. Integrated DNA Technologies, Inc. Recent Development

Table 68. Illumina, Inc. Company Detail

Table 69. Illumina, Inc. Business Overview

Table 70. Illumina, Inc. Onco-hematology Molecular Testing Product

Table 71. Illumina, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023) & (US$ Million)

Table 72. Illumina, Inc. Recent Development

Table 73. Invivoscribe, Inc. Company Detail

Table 74. Invivoscribe, Inc. Business Overview

Table 75. Invivoscribe, Inc. Onco-hematology Molecular Testing Product

Table 76. Invivoscribe, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023) & (US$ Million)

Table 77. Invivoscribe, Inc. Recent Development

Table 78. QIAGEN N.V. Company Detail

Table 79. QIAGEN N.V. Business Overview

Table 80. QIAGEN N.V. Onco-hematology Molecular Testing Product

Table 81. QIAGEN N.V. Revenue in Onco-hematology Molecular Testing Business (2018-2023) & (US$ Million)

Table 82. QIAGEN N.V. Recent Development

Table 83. Thermo Fisher Scientific, Inc. Company Detail

Table 84. Thermo Fisher Scientific, Inc. Business Overview

Table 85. Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Product

Table 86. Thermo Fisher Scientific, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023) & (US$ Million)

Table 87. Thermo Fisher Scientific, Inc. Recent Development

Table 88. Cepheid Company Detail

Table 89. Cepheid Business Overview

Table 90. Cepheid Onco-hematology Molecular Testing Product

Table 91. Cepheid Revenue in Onco-hematology Molecular Testing Business (2018-2023) & (US$ Million)

Table 92. Cepheid Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Onco-hematology Molecular Testing Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global Onco-hematology Molecular Testing Market Share by Type: 2022 VS 2029

Figure 3. qPCR Features

Figure 4. dPCR Features

Figure 5. Next-Generation Sequencing Features

Figure 6. Others Features

Figure 7. Global Onco-hematology Molecular Testing Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 8. Global Onco-hematology Molecular Testing Market Share by Application: 2022 VS 2029

Figure 9. National Reference Lab / Specialty Lab Case Studies

Figure 10. University Hospital Case Studies

Figure 11. Community Hospital Case Studies

Figure 12. Onco-hematology Molecular Testing Report Years Considered

Figure 13. Global Onco-hematology Molecular Testing Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 14. Global Onco-hematology Molecular Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Onco-hematology Molecular Testing Market Share by Region: 2022 VS 2029

Figure 16. Global Onco-hematology Molecular Testing Market Share by Players in 2022

Figure 17. Global Top Onco-hematology Molecular Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onco-hematology Molecular Testing as of 2022)

Figure 18. The Top 10 and 5 Players Market Share by Onco-hematology Molecular Testing Revenue in 2022

Figure 19. North America Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. North America Onco-hematology Molecular Testing Market Share by Country (2018-2029)

Figure 21. United States Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Europe Onco-hematology Molecular Testing Market Share by Country (2018-2029)

Figure 25. Germany Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. France Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. U.K. Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Italy Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Russia Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Nordic Countries Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Asia-Pacific Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Asia-Pacific Onco-hematology Molecular Testing Market Share by Region (2018-2029)

Figure 33. China Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Japan Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. South Korea Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Southeast Asia Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. India Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Australia Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 39. Latin America Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Latin America Onco-hematology Molecular Testing Market Share by Country (2018-2029)

Figure 41. Mexico Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Brazil Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Middle East & Africa Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Middle East & Africa Onco-hematology Molecular Testing Market Share by Country (2018-2029)

Figure 45. Turkey Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Saudi Arabia Onco-hematology Molecular Testing Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Asusragen, Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2018-2023)

Figure 48. Bio-Rad Laboratories,Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2018-2023)

Figure 49. ICON Plc Revenue Growth Rate in Onco-hematology Molecular Testing Business (2018-2023)

Figure 50. Integrated DNA Technologies, Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2018-2023)

Figure 51. Illumina, Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2018-2023)

Figure 52. Invivoscribe, Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2018-2023)

Figure 53. QIAGEN N.V. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2018-2023)

Figure 54. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2018-2023)

Figure 55. Cepheid Revenue Growth Rate in Onco-hematology Molecular Testing Business (2018-2023)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Onco-hematology Molecular Testing Market Research Report 2023

Published Date: July 2023

Report Code: QYRE-Auto-13I14977

Global Onco-hematology Molecular Testing Market Research Report 2023

FEATURED COMPANIES

Onco-hematology Molecular Testing Market Size

Onco-hematology Molecular Testing Market

Report Scope

Scope of Onco-hematology Molecular Testing Market Report

FAQ for this report

How fast is Onco-hematology Molecular Testing Market market growing?

What is the Onco-hematology Molecular Testing Market market size in 2029?

FEATURED COMPANIES